Click for best price
Specialty Pharmaceuticals Market Size, Share 2022
Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.
This report contains market size and forecasts of Specialty Pharmaceuticals in Global, including the following market information:
Global Specialty Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Specialty Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Pharmaceuticals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Specialty Pharmaceuticals include Teva Pharmaceuticals, Abbvie, Amgen, Johnson & Johnson, Celgene, Gilead Sciences and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Specialty Pharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Specialty Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Specialty Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Oral Pharmaceuticals
Parenteral Pharmaceuticals
Transdermal Pharmaceuticals
Global Specialty Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Specialty Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Hospitals
Retail Pharmacies
Specialty Pharmacies
Mail Order
Global Specialty Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Specialty Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Specialty Pharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Specialty Pharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceuticals
Abbvie
Amgen
Johnson & Johnson
Celgene
Gilead Sciences
Roche
| Report Attributes |
Report Details |
| Report Title |
Specialty Pharmaceuticals Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Specialty Pharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Specialty Pharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Specialty Pharmaceuticals Overall Market Size
2.1 Global Specialty Pharmaceuticals Market Size: 2021 VS 2028
2.2 Global Specialty Pharmaceuticals Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Specialty Pharmaceuticals Players in Global Market
3.2 Top Global Specialty Pharmaceuticals Companies Ranked by Revenue
3.3 Global Specialty Pharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Specialty Pharmaceuticals Companies in Global Market, by Revenue in 2021
3.5 Global Companies Specialty Pharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Specialty Pharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Specialty Pharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Specialty Pharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Specialty Pharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 Oral Pharmaceuticals
4.1.3 Parenteral Pharmaceuticals
4.1.4 Transdermal Pharmaceuticals
4.2 By Type - Global Specialty Pharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Specialty Pharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global Specialty Pharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Specialty Pharmaceuticals Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Retail Pharmacies
5.1.4 Specialty Pharmacies
5.1.5 Mail Order
5.2 By Application - Global Specialty Pharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Specialty Pharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global Specialty Pharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Specialty Pharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global Specialty Pharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Specialty Pharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global Specialty Pharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Specialty Pharmaceuticals Revenue, 2017-2028
6.3.2 US Specialty Pharmaceuticals Market Size, 2017-2028
6.3.3 Canada Specialty Pharmaceuticals Market Size, 2017-2028
6.3.4 Mexico Specialty Pharmaceuticals Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Specialty Pharmaceuticals Revenue, 2017-2028
6.4.2 Germany Specialty Pharmaceuticals Market Size, 2017-2028
6.4.3 France Specialty Pharmaceuticals Market Size, 2017-2028
6.4.4 U.K. Specialty Pharmaceuticals Market Size, 2017-2028
6.4.5 Italy Specialty Pharmaceuticals Market Size, 2017-2028
6.4.6 Russia Specialty Pharmaceuticals Market Size, 2017-2028
6.4.7 Nordic Countries Specialty Pharmaceuticals Market Size, 2017-2028
6.4.8 Benelux Specialty Pharmaceuticals Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Specialty Pharmaceuticals Revenue, 2017-2028
6.5.2 China Specialty Pharmaceuticals Market Size, 2017-2028
6.5.3 Japan Specialty Pharmaceuticals Market Size, 2017-2028
6.5.4 South Korea Specialty Pharmaceuticals Market Size, 2017-2028
6.5.5 Southeast Asia Specialty Pharmaceuticals Market Size, 2017-2028
6.5.6 India Specialty Pharmaceuticals Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Specialty Pharmaceuticals Revenue, 2017-2028
6.6.2 Brazil Specialty Pharmaceuticals Market Size, 2017-2028
6.6.3 Argentina Specialty Pharmaceuticals Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Specialty Pharmaceuticals Revenue, 2017-2028
6.7.2 Turkey Specialty Pharmaceuticals Market Size, 2017-2028
6.7.3 Israel Specialty Pharmaceuticals Market Size, 2017-2028
6.7.4 Saudi Arabia Specialty Pharmaceuticals Market Size, 2017-2028
6.7.5 UAE Specialty Pharmaceuticals Market Size, 2017-2028
7 Players Profiles
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Corporate Summary
7.1.2 Teva Pharmaceuticals Business Overview
7.1.3 Teva Pharmaceuticals Specialty Pharmaceuticals Major Product Offerings
7.1.4 Teva Pharmaceuticals Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.1.5 Teva Pharmaceuticals Key News
7.2 Abbvie
7.2.1 Abbvie Corporate Summary
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Specialty Pharmaceuticals Major Product Offerings
7.2.4 Abbvie Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.2.5 Abbvie Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Specialty Pharmaceuticals Major Product Offerings
7.3.4 Amgen Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.3.5 Amgen Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Specialty Pharmaceuticals Major Product Offerings
7.4.4 Johnson & Johnson Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Specialty Pharmaceuticals Major Product Offerings
7.5.4 Celgene Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Specialty Pharmaceuticals Major Product Offerings
7.6.4 Gilead Sciences Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Specialty Pharmaceuticals Major Product Offerings
7.7.4 Roche Specialty Pharmaceuticals Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Specialty Pharmaceuticals Market Opportunities & Trends in Global Market
Table 2. Specialty Pharmaceuticals Market Drivers in Global Market
Table 3. Specialty Pharmaceuticals Market Restraints in Global Market
Table 4. Key Players of Specialty Pharmaceuticals in Global Market
Table 5. Top Specialty Pharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Specialty Pharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Specialty Pharmaceuticals Revenue Share by Companies, 2017-2022
Table 8. Global Companies Specialty Pharmaceuticals Product Type
Table 9. List of Global Tier 1 Specialty Pharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Specialty Pharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Specialty Pharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Specialty Pharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Specialty Pharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Specialty Pharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Specialty Pharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Specialty Pharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Specialty Pharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Specialty Pharmaceuticals Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Specialty Pharmaceuticals Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Specialty Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Specialty Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Specialty Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Specialty Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Specialty Pharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceuticals Corporate Summary
Table 31. Teva Pharmaceuticals Specialty Pharmaceuticals Product Offerings
Table 32. Teva Pharmaceuticals Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 33. Abbvie Corporate Summary
Table 34. Abbvie Specialty Pharmaceuticals Product Offerings
Table 35. Abbvie Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Specialty Pharmaceuticals Product Offerings
Table 38. Amgen Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Specialty Pharmaceuticals Product Offerings
Table 41. Johnson & Johnson Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Specialty Pharmaceuticals Product Offerings
Table 44. Celgene Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences Specialty Pharmaceuticals Product Offerings
Table 47. Gilead Sciences Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Specialty Pharmaceuticals Product Offerings
Table 50. Roche Specialty Pharmaceuticals Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Specialty Pharmaceuticals Segment by Type in 2021
Figure 2. Specialty Pharmaceuticals Segment by Application in 2021
Figure 3. Global Specialty Pharmaceuticals Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Specialty Pharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Specialty Pharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Specialty Pharmaceuticals Revenue in 2021
Figure 8. By Type - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 9. By Application - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 10. By Region - Global Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Country - North America Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 12. US Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 16. Germany Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 17. France Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 24. China Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. India Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 30. Brazil Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Specialty Pharmaceuticals Revenue Market Share, 2017-2028
Figure 33. Turkey Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Specialty Pharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceuticals Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbvie Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Specialty Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
